Digital
Therapeutics
Personalised care beyond the hospital and clinics.
We empower patients with mental health conditions and chronic diseases to stay healthy at home and in the community. Every day, our digital tools are used by thousands of people to manage their conditions in an effective and engaging way.
Our Approach
Technology will radically change how healthcare is delivered: enabling better quality of care & patient experience at a massive scale. We’re building a new, digital future.
We draw upon the latest in consumer technology to deliver a complete patient experience through your mobile phone: simple to use, highly personalised and accessible whenever you need it.
Our digital therapeutics actively & passively track, monitor and treat patients. We do this using a blend of artificial intelligence and expert coaching, backed by powerful data analytics. Ultimately, we help patients transform healthy choices into lifelong habits. We’ve developed our products on a strong foundation in medical and behavioural science. They are capable of delivering clinically significant health outcomes. Today, we support patients with diabetes, prediabetes, high blood pressure, high cholesterol and obesity, and are expanding to mental health - starting with major depressive disorder.
Our Products
GlycoLeap
Get on the right track to prevent or control diabetes. And achieve a healthier weight in 3 - 6 months. Our mobile dietitian coach will be your personal, expert companion. So you can worry less and live more.
Learn more >
SuperLeap
Our expert coaches support you and your child through the app and on the phone. They'll work with you to set and achieve your food and exercise goals.
Learn more >
Use Cases
Singapore diabetes management study
Read more >
Singapore diabetes management study
In an independent clinical validation of GlycoLeap efficacy, we tracked 80 users on our 24 week digital diabetes management program. Participants had no rewards or provided incentives.
At the end of the study, participants achieved and average percentage point decrease in HbA1c of 1.3% and an average weight loss of 1.9 kg over 6 months.
Engagement Case Study
Read more >
Engagement case study
In 2017, Glycoleap was used in a pilot project for a subset of medical insured members in Singapore. The study, which ran over a week, measured the effect of incentives of customer engagement.
Using a points based incentive scheme (where points translate to reward currency) we were able to increased user engagement with GlycoLeap by ~100%, with 73% of the participants in the study period becoming eligible for the reward.
Digital Therapeutics for Major Depression
Read more >
Digital Therapeutic for Major Depression
Holmusk is in the process of developing a digital therapeutic solution for major depressive disorder, a disorder with one of the highest unmet care needs. The solution being developed aims to address the inability of patient to effectively articulate their condition and the intermittent data collection for mental health only in the clinical setting. These challenges will be combated through the development of an AI powered platform that generates a psychological persona of the patients based on their data (active and passive), providing an objective view of the patient’s condition, state and future projection to enable effective consultations.
